Literature DB >> 3908292

Leukaemia x fibroblast hybrid cells augment the antibody response to sheep red blood cells in inbred mice.

E P Cohen, K Hagen.   

Abstract

ASL-1 x LM(TK-) hybrid cells, an established murine leukaemia x fibroblast hybrid cell line, augment the antibody response to sheep red blood cells in inbred mice, as determined by the plaque assay method. The intraperitoneal injection of viable hybrid cells or of growth medium conditioned by the cells leads to an increase both in the total number as well as the proportion of cells forming antibodies to sheep red blood cells. CSF-1, (M-CSF), is detected by radioimmunoassay in the medium conditioned by the hybrid and LM(TK-) cells, but not ASL-1 parental cells. Prior treatment of the conditioned medium with CSF-1 antiserum reduces its capacity to augment the antibody response, and its proliferative stimulus on cells from the marrow indicating that CSF-1 may be at least partly responsible for the adjuvant effect observed. The intraperitoneal implantation of diffusion chambers containing viable CSF-1 producing hybrid cells, like the cells themselves, also leads to an increase in the number of spleen cells forming antibodies to sheep red blood cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3908292      PMCID: PMC1453797     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  23 in total

1.  Methods for the purification, assay, characterization and target cell binding of a colony stimulating factor (CSF-1).

Authors:  E R Stanley; L J Guilbert
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

2.  Stimulation of macrophage plasminogen activator activity by colony-stimulating factors.

Authors:  J A Hamilton; E R Stanley; A W Burgess; R K Shadduck
Journal:  J Cell Physiol       Date:  1980-06       Impact factor: 6.384

3.  Factors regulating macrophage production and growth: identity of colony-stimulating factor and macrophage growth factor.

Authors:  E R Stanley; M Cifone; P M Heard; V Defendi
Journal:  J Exp Med       Date:  1976-03-01       Impact factor: 14.307

4.  Induction of prostaglandin E synthesis in normal and neoplastic macrophages: role for colony-stimulating factor(s) distinct from effects on myeloid progenitor cell proliferation.

Authors:  J I Kurland; L M Pelus; P Ralph; R S Bockman; M A Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

5.  Colony-stimulating factor (CSF) radioimmunoassay: detection of a CSF subclass stimulating macrophage production.

Authors:  E R Stanley
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

6.  Surface antigens of immunoprotective leukaemia x fibroblast hybrid cells which have lost malignant properties in histocompatible mice differ from the malignant parental cells.

Authors:  R Slomski; D R Wang; E P Cohen
Journal:  Immunology       Date:  1984-06       Impact factor: 7.397

7.  Persistence of the immunoprotective effects of leukemia X fibroblast hybrid cells toward leukemia in histocompatible mice.

Authors:  S L Garber; E P Cohen; I Chang
Journal:  Leuk Res       Date:  1984       Impact factor: 3.156

8.  Leukemia X fibroblast hybrid cells prolong the lives of leukemic mice.

Authors:  D R Wang; R Slomski; E P Cohen
Journal:  Eur J Cancer Clin Oncol       Date:  1985-05

9.  Tumor-specific immunity induced by somatic hybrids. I. Lack of relationship between immunogenicity and tumorigenicity of selected hybrids.

Authors:  B S Kim; W Liang; E P Cohen
Journal:  J Immunol       Date:  1979-08       Impact factor: 5.422

10.  Production of lymphocyte-activating factor (Interleukin 1) by macrophages activated with colony-stimulating factors.

Authors:  R N Moore; J J Oppenheim; J J Farrar; C S Carter; A Waheed; R K Shadduck
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

View more
  1 in total

1.  Immunity to melanoma in mice immunized with transfected allogeneic mouse fibroblasts expressing melanoma-associated antigens.

Authors:  Y S Kim; R Slomski; E P Cohen
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.